Immatics Archives -

Cancer biotech Immatics has begun a collaboration with GlaxoSmithKline to develop novel therapies built around its T-cell-based technology.

GSK begins cancer cell therapy tie-up with Immatics

https://pharmaphorum.com/news/gsk-begins-cancer-cell-therapy-tie-up-with-immatics/

Celgene shows no sign of slowing down on the deal-making front as its merger with Bristol-Myers Squibb draws

Celgene strikes $1.5bn cell therapy deal with Immatics

https://pharmaphorum.com/news/celgene-strikes-1-5bn-cell-therapy-deal-with-immatics/

European biotech: a mixture of encouraging clinical trials and new funding lift the sector.

European biotech round-up: Ablynx’s big break and more

https://pharmaphorum.com/views-and-analysis/european-biotech-round-ablynxs-big-break/

Companies to develop bispecific antibodies.

Amgen, Immatics strike $1bn cancer R&D deal

https://pharmaphorum.com/news/amgen-immatics-strike-1bn-cancer-rd-deal/

Immatics